| |
| |
| Veeda biostatisticians have decades of experience in designing and analyzing oncology studies.
Biostatistics participates in all aspects of the
clinical trial process. At the protocol design stage, we can provide support for scenario analysis in the sample size and power estimations. Assessments typically include endpoint differences based upon overall and progression-free survival, tumor response rates, and quality of life assessments. Veeda
biostatisticians can also dialogue with regulatory authorities to ensure agreement on the analysis strategy, dialogue can continue up through market approval if necessary. Additionally, the biostatistical staff can assist the computer and regulatory groups in the preparation of CANDAs, and incorporate the necessary data tabulations for further regulatory analysis and graphical displays. |
| |
| Detailed statistical analysis plans are written that reflect the statistical section of the protocol. This plan drives the analysis that is needed for all tables, listings and graphs required for a study. Statistical analyses are performed in SAS®. |
